OSNIVAČI


Doc. dr Aleksandar Sovtić

PREDSEDNIK UDRUŽENJA

Institut za zdravstvenu zaštitu majke i deteta Srbije

DATUM I MESTO ROĐENJA

4. april 1971, Beograd

TRENUTNO ZAPOSLENJE

  • Docent, Medicinski fakultet Univerziteta u Beogradu.
  • Načelnik odeljenja pulmologije, Institut za zdravstvenu zaštitu majke i deteta Srbije „Dr Vukan Čupić“.

KONTAKT

Adresa: Radoja Dakića 6, 11070 Beograd
Telefon/faks: 011 31 08 158

OBRAZOVANJE

  • 1989–1995 Medicinski fakultet, Univerzitet u Beogradu. Diplomirao sa prosečnom ocenom u toku studija od 9,33.
  • 1995–2000 Magistarske studije iz pulmologije - Medicinski fakultet, Univerzitet u Beogradu.
  • 1996–2000 Specijalizacija iz pedijatrije - Medicinski fakultet, Univerzitet u Beogradu. Specijalistički ispit položen pred komisijom Instituta za zdravstvenu zaštitu majke i deteta Srbije s odličnim uspehom.
  • 2004 Odbranjen magistarski rad iz pulmologije pod nazivom: „Uticaj inhalacijskih kortikosteroida na linearni rast dece sa astmom”. Medicinski fakultet, Univerzitet u Beogradu.
  • 2013 Odbranjena doktorska disertacija (uža naučna oblast pulmologija) pod nazivom: „Procena aerobnog kapaciteta i indeksa disajne reserve obolelih od cistične fibroze”. Medicinski fakultet, Univerzitet u Beogradu.
  • 2016 Odbranjen rad uže specijalizacije iz pulmologije pod nazivom: “Ispitivanje snage disajnih mišića kod obolelih od cistične fibroze u odnosu na stepen tolerancije napora u toku ergospirometrije”. Medicinski fakultet, Univerzitet u Beogradu.

KRETANJE U SLUŽBI

  • 2000 – Lekar u Službi za ispitivanje i lečenje bolesti pluća, Institut za zdravstvenu zaštitu majke i deteta Srbije.

STIPENDIJE I USAVRŠAVANJE U INOSTRANSTVU

  • 2003 (Mart – Jun) Odeljenje pulmologije i pedijatrijske intenzivne nege. Pedijatrijska klinika, Mt. Sinai Hospital, Mt. Sinai School of Medicine, Njujork, SAD.
  • 2003 (Jun) Odeljenje pedijatrijske pulmologije, Pedijatrijska klinika, Children’s Hospital, Columbia University, Njujork, SAD.
  • 2003 Kurs: “Advanced paediatric respiratory medicine” – Škola Evropskog respiratornog
  • Udruženja („European respiratory society“ - ERS) - učešće podržano stipendijom ERSa – Barselona, Španija.
  • 2004 Kurs “Cystic fibrosis – state of the art” – Škola Evropskog respiratornog udruženja – Beč, Austrija.
  • 2005 (Avgust) Odeljenje za pedijatrijsku pulmologiju i centar za cističnu fibrozu. Hôpital d̓ enfants Armand Trousseau, Pariz, Francuska.
  • 2005 Kurs “Non - invasive positive pressure ventilation – state of the art” – Škola ERS. učešće podržano stipendijom ERSa – Piza, Italija.
  • 2006 6th paediatric bronchology course – Imperial College and Royal Brompton hospital, London, UK.
  • 2006 Kurs "Basic principles of clinical exercise testing" – Škola Evropskog respiratornog Udruženja – Rim, Italija
  • 2007 Kurs “Infant pulmonary function testing” – Škola Evropskog respiratornog udruženja – Nica, Francuska.
  • 2016 The European Workshop on Clinical Pediatric Exercise Testing (EWCPET 2016) – Utreht, Holandija

STIPENDIJE I USAVRŠAVANJE U ZEMLJI

  • 2007 Kurs dobre kliničke prakse – Udruženje profesionalaca u kliničkim ispitivanjima (ACRP), Beograd.
  • 2014 Kurs poligrafije (Scoring Course PG Basic, Poligraphy) – Beograd, Srbija
  • 2015 Kurs poligrafije (Scoring Course PG Advanced, Poligraphy) – Beograd, Srbija

ČLANSTVA

  • Evropsko respiratorno udruženje
  • Evropsko udruženje za cističnu fibrozu
  • Američko udruženje grudnih lekara („American thoracic society“)
  • Udruženje pedijatara Srbije
  • Udruženje za cističnu fibrozu Srbije
  • Udruženje profesionalaca u kliničkim ispitivanjima („Association of clinical research professionals“)
  • Hilandarsko lekarsko društvo

OBLASTI ISTRAŽIVANJA

  • Respiratorna fiziologija, funkcionalna dijagnostika, poremećaji disanja u spavanju, pedijatrijska bronhologija.

UČEŠĆE U INTERNACIONALNIM MUTICENTRIČNIM KLINIČKIM STUDIJAMA

  • Efficacy and safety of ciclesonide in adolescents with asthma. A randomized, double-blind, double dummy, parallel group, multicenter study. ESSENCE BY 9010/M1-139. INVESTIGATOR.
  • Treatment of asthma in pediatric patients. Comparation of inhaled ciclesonide 160 mcg/day and budesonide 400 mcg/day. PeP-Study. BY9010/M1-204. INVESTIGATOR.
  • Safety and tolerability study of SLIT™ Amikacin 500 mg once daily for 14 days by inhalation in cystic fibrosis study subjects chronicaly infected with pseudomonas aeruginosa. TR02-103. INVESTIGATOR.
  • A Randomized, Double-blind Placebo-controlled, Multicenter, Phase 3 trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects. TIP002 Study. INVESTIGATOR.
  • Pharmacokinetics of the pharmacologically active metabolite M1 of ciclesonide after inhalation of ciclesonide via MDI with and without AeroChamber Plus spacer in asthmatic children. BY9010/CP-037. INVESTIGATOR
  • Multidose safety nad tolerability study of dose escalation of liposomal amikacin for inhalation (ARIKACE) in cystic fibrosis patients with chronic infection due to pseudomonas aeruginosa TR02-105. INVESTIGATOR.
  • A Phase III, randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of ALTU-135 treatment in patients with cystic fibrosis-related exocrine pancreatic insufficiency. INVESTIGATOR.
  • A Open-Label clinical study evaluating the long-term safety of ALTU-135 for the treatment of patients with cystic fibrosis-related exocrine pancreatic insufficiency. INVESTIGATOR.
  • Multidose safety nad tolerability study of dose escalation of liposomal amikacin for inhalation (ARIKACE) in cystic fibrosis patients with chronic infection due to pseudomonas aeruginosa TR02-105 – Extension study. INVESTIGATOR.
  • Randomized open-label, active-controlled, multicenter study to assess the efficacy, safety and tolerability of Arikace in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa TR02-108. INVESTIGATOR.
  • Long Term Safety and Tolerability of Open-Label Liposomal Amikacin for Inhalation (Arikace™) in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa TR02-110. INVESTIGATOR.
  • A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects DPM‐CF‐303. PRINCIPAL INVESTIGATOR
  • A Phase III, Randomiyed, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapz Tablet, in Children With History of Ragweed – Induced Rhinoconjunctivitis With or Without Asthma. INVESTIGATOR
  • A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate Multiple Doses of GLPG2222 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation. INVESTIGATOR
  • „A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma“
  • A phase 2 study of ABBV-3067 Alone and in Combination with ABBV-2222 in Cystic fibrosis Subjects who are Homozygous for the F508del mutation. INVESTIGATOR.

UČEŠĆE U PROJEKTIMA

  • Projekat "Primarna zdravstvena zaštita majke i deteta" - edukativni seminari za lekare u primarnoj zdravstvenoj zaštiti, Nosilac Projekta: Institut za zdravstvenu zaštitu majke i deteta Srbije, uz podršku UNICEF-a. Ekspert-predavač za temu: Akutne respiratorne infekcije, 2004-2005. godine.
  • Projekat "Racionalna primena antibiotika u pedijatriji". Nosilac Projekta: Ministarstvo zdravlja Republike Srbije i Udruženje pedijatara Srbije, 2016-2017.

ČLANSTVO U UREDNIŠTVU NAUČNIH PUBLIKCIJA

  • 1997 “Problemi u pedijatriji”

RECENZENT NAUČNIH PUBLIKACIJA

  • Frontiers in Pediatrics
  • Respiratory Care

OSTALE VEŠTINE

  • Pišem, čitam i govorim engleski jezik
  • Služim se francuskim jezikom

ZNAČAJNIJE REFERENCE U STRUČNIM PUBLIKACIJAMA

  • Sovtic A. Diagnosis of cystic fibrosis-related diabetes: too early or too late? J Brasil Pneumol 2022; 20:48.
  • Markovic-Sovtic G, Djuricic S, Sovtic A, Minic P, Rakonjac Z, Colmero I. Neonatal generalized lymphatic anomaly (GLA) with skin involvement. Ann Dermatol 2021.
  • Sovtic A, Grba T, Grahovac D, Minic P. Flexible Bronchoscopy in Evaluation of Persistent Wheezing in Children — Experiences from National Pediatric Center. Medicina 2020; 56: 329 .
  • Basa M, Minic P, Rodic M, Sovtic A. (corresponding author). Evolution of pediatric home mechanical ventilation program in serbia – what has changed in the last decade. Front Ped 2020; 8:261. M21, IF 2,349.
  • Plavsic L, Knezevic M, Sovtic A, Minic P, Vukovic R, Mazibrada I, Stanojlovic O, Hrncic D, Rasic-Markovic A, Macut D.Effects of high-intensity interval training and nutrition advice on cardiometabolic markers and aerobic fitness in adolescent girls with obesity. Appl Physiol Nutr Metab. 2020; 45: 294-300.
  • Paglietti M, Porcaro F, Sovtic A, Cherchi C, Verrillo E, Pavone M, Bottero S, Cutrera R. Decanulation in children affected by congenital central hypoventilation syndrome: A proposal of an algorithm from two European centers. Pediatr Pulmonol 2019; 54: 1663-9.
  • Anđelković M, Spasovski V, Vreća M, Sovtić A, Rodić M, Komazec J, Pavlović S, Minić P. The importance of genomic profiling for differential diagnosis of pediatric lung disease patients with suspected ciliopathies. Srp Arh Celok Lek 2019│Online First March 4, 2019.
  • Andjelkovic M, Minic P, Vreca M, Stojiljkovic M, Skakic A, Sovtic A, Rodic M, Skodric-Trifunovic V, Maric N, Visekruna J, Spasovski V, Pavlovic S. Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants. PLoS One. 2018 Oct 9;13(10):e0205422.
  • Sovtic A, Minic P, Markovic-Sovtic G, Trajkovic G. Respiratory muscle strength and exercise performance in cystic fibrosis–A cross sectional study. Front Pediatr 2018; 6:244.
  • Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, et al. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. Ann Am Thorac Soc 2018;15(2):209-216.
  • Malešević M, Vasiljević Z, Sovtić A, Filipić B, Novović K, Kojić M, Jovčić B. Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients. Antimicrob Resist Infect Control. 2017 Jun 6;6:5.
  • Minic P, Sovtic A. Exercise intolerance and exercise-induced bronchoconstriction in children. Front Biosci 2017; 9:21-32.
  • Vasiljevic Z, Novovic K, Kojic M, Minic P, Sovtic A, Djukic S, Jovcic B. Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology. Eur J Clin Microbiol Infect Dis 2016; 35:1277-84.
  • Marković D, Perić T, Sovtić A, Minić P, Mirković B. Stanje oralnog zdravlja kod dece obolele od astme. Srp Arh Celok Lek 2015;143:539-44.
  • Baljosevic I, Minic P, Trajkovic G, Markovic-Sovtic G, Radojicic B, Sovtic A (corresponding author). Evaluation of surgical treatment of severe laryngomalacia – follow up study. Pediatr Int 2015; 57:1159-63.
  • Sovtic A, Minic P, Kosutic J, Markovic-Sovtic G, Gajic M. Modified Chrispin-Norman score: correlation with peak exercise capacity and efficiency of ventilation in children with cystic fibrosis. Pediatr Exerc Sci 2014; 26:259-65.
  • Markovic-Sovtic G, Kosutic J, Jankovic B, Bojanin D, Sovtic A, Radojicic Z, et al. NT-pro BNP In Assessment Of Respiratory Distress In Term Neonates. Pediatr Int 2014; 56:373-7.
  • Sovtic A, Minic P, Kosutic J, Markovic-Sovtic G, Gajic M. Static hyperinflation is associated with decreased exercise performance in children with cystic fibrosis. Respir Care 2013; 58:291–7.
  • Radivojevic D, Sovtic A, Minic P, Grkovic S, Guc-Scekic M, Lalic T, et al. Newborn screening for cystic fibrosis in Serbia – a pilot study. Pediatr Int 2013; 55:181-4.
  • Sovtic A, Minic P, Vukcevic M, Markovic-Sovtic G, Rodic M, Gajic M. Home mechanical ventilation in children is feasible in developing countries. Pediatr Int 2012; 54:676-81.
  • Kosutic J, Minic P, Sovtic A, Prijic S. Upper lung lobe systemic artery-pulmonary vein fistula with signs and symptoms of congestive heart failure: successful treatment with coil embolization. J Vasc Interv Radiol 2007; 18:299-302.
  • Sovtić A, Minić P, Bogdanović R, Stajić N, Rodić M, Marković-Sovtić G. Atypical presentation of cystic fibrosis – obese adolescent with hypertension and Pseudo-Bartter’s syndrome. Vojnosanit Pregl 2012; 64:367-9.
PREDSEDNIK UDRUŽENJA
Institut za zdravstvenu zaštitu majke i deteta Srbije

Prof. dr Gordana Vilotijević Dautović 

Institut za zdravstvenu zaštitu dece i omladine Vojvodine
Klinika za pedijatriju Univerzitetskog kliničkog centra Niš
Klinika za pedijatriju, Univerzitetski klinički centar Kragujevac
Univerzitetska dečja klinika Tiršova

© Copyright 2023 Pedijatrijsko respiratorno udruženje Srbije. All Rights Reserved.

No Code Website Builder